Gilberto Vaughan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gilberto Vaughan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- David Stiven Campo
Centers for Disease Control and Prevention
2 shared publications - Joseph C. Forbi
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
2 shared publications - Pavel Skums
Molecular Epidemiology and Bioinformatics Laboratory, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, USA
2 shared publications - Yury Khudyakov
Centers for Disease Control and Prevention
2 shared publications - Zoya Dimitrova
Molecular Epidemiology and Bioinformatics Laboratory, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, USA
2 shared publications - Alex Zelikovsky
Georgia State University
1 shared publication
Latest Publications
- Open Access
- 14 July 2014
- Published by Springer Nature in BMC Genomics
- Vol. 15 (S5) , S4
Next-generation sequencing reveals large connected networks of intra-host HCV variants
Next-generation sequencing (NGS) allows for sampling numerous viral variants from infected patients. This provides a novel opportunity to represent and study the mutational landscape of Hepatitis C Virus (HCV) within a single host.
- 14 July 2014
- Published by Springer Nature in BMC Genomics
- Vol. 15 (S5) , S4
Open AccessNext-generation sequencing reveals large connected networks of intra-host HCV variants
Next-generation sequencing (NGS) allows for sampling numerous viral variants from infected patients. This provides a novel opportunity to represent and study the mutational landscape of Hepatitis C Virus (HCV) within a single host.
- Open Access
- 25 June 2012
- Published by Springer Nature in BMC Bioinformatics
- Vol. 13 (S10) , S6
Efficient error correction for next-generation sequencing of viral amplicons
Next-generation sequencing allows the analysis of an unprecedented number of viral sequence variants from infected patients, presenting a novel opportunity for understanding virus evolution, drug resistance and immune escape. However, sequencing in bulk is error prone. Thus, the generated data require error identification and correction. Most error-correction methods to date are not optimized for amplicon analysis and assume that the error rate is randomly distributed. Recent quality assessment of amplicon sequences obtained using 454-sequencing showed that the error rate is strongly linked to the presence and size of homopolymers, position in the sequence and length of the amplicon. All these parameters are strongly sequence specific and should be incorporated into the calibration of error-correction algorithms designed for amplicon sequencing.
- 25 June 2012
- Published by Springer Nature in BMC Bioinformatics
- Vol. 13 (S10) , S6
Open AccessEfficient error correction for next-generation sequencing of viral amplicons
Next-generation sequencing allows the analysis of an unprecedented number of viral sequence variants from infected patients, presenting a novel opportunity for understanding virus evolution, drug resistance and immune escape. However, sequencing in bulk is error prone. Thus, the generated data require error identification and correction. Most error-correction methods to date are not optimized for amplicon analysis and assume that the error rate is randomly distributed. Recent quality assessment of amplicon sequences obtained using 454-sequencing showed that the error rate is strongly linked to the presence and size of homopolymers, position in the sequence and length of the amplicon. All these parameters are strongly sequence specific and should be incorporated into the calibration of error-correction algorithms designed for amplicon sequencing.